Cellular parameters shaping pathways of targeted protein degradation
- PMID: 40316744
- PMCID: PMC12048530
- DOI: 10.1038/s42003-025-08104-w
Cellular parameters shaping pathways of targeted protein degradation
Abstract
In recent years the development of proteolysis-targeting chimeras (PROTACs) has enhanced the field of ubiquitin signalling through advancing therapeutic targeted protein degradation (TPD) strategies and generating tools to explore the ubiquitin landscape. However, the interplay between PROTACs and their substrates, and other components of the ubiquitin proteasome system (UPS), raises fundamental questions about cellular parameters that might influence the action of PROTACs and the amenability of a given target to PROTAC-mediated degradation. In this perspective we discuss examples of cellular parameters that have been shown to influence PROTAC sensitivity and consider others likely to be important for PROTAC-mediated target degradation but not yet routinely considered in design of novel TPD strategies: Target localisation and accessibility on the one hand, and expression patterns, localisation and activity of E3 ligases, deubiquitinases (DUBs) and wider ubiquitin machinery on the other, are critical parameters in the exploitation of PROTACs, and establishing a better understanding of these parameters will facilitate the rational design of PROTACs.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Proteasome substrate receptors and their therapeutic potential.Trends Biochem Sci. 2022 Nov;47(11):950-964. doi: 10.1016/j.tibs.2022.06.006. Epub 2022 Jul 9. Trends Biochem Sci. 2022. PMID: 35817651 Free PMC article. Review.
-
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.Mol Cancer. 2024 Jul 25;23(1):148. doi: 10.1186/s12943-024-02046-3. Mol Cancer. 2024. PMID: 39048965 Free PMC article. Review.
-
Proteolysis-targeting chimeras (PROTACs) in cancer therapy.Mol Cancer. 2022 Apr 11;21(1):99. doi: 10.1186/s12943-021-01434-3. Mol Cancer. 2022. PMID: 35410300 Free PMC article. Review.
-
PROTAC-induced protein structural dynamics in targeted protein degradation.Elife. 2025 Feb 27;13:RP101127. doi: 10.7554/eLife.101127. Elife. 2025. PMID: 40014381 Free PMC article.
-
Applications of protein ubiquitylation and deubiquitylation in drug discovery.J Biol Chem. 2024 May;300(5):107264. doi: 10.1016/j.jbc.2024.107264. Epub 2024 Apr 4. J Biol Chem. 2024. PMID: 38582446 Free PMC article. Review.
References
-
- Chau, V. et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243, 1576–1583 (1989). - PubMed
-
- Matsumoto, M. L. et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol. Cell39, 477–484 (2010). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources